APOE and tauopathy: Together, these findings validated the in vivo relevance of the mechanism identified in vitro and confirmed that TRPV1 regulates microglial cholesterol metabolism and immune function, thus suggesting potential therapeutic targets to prevent APOE4-related immune response in tauopathies.